STAT3: A Potential Drug Target for Tumor and Inflammation

被引:62
|
作者
Hu, Yang Sheng [1 ]
Han, Xu [1 ]
Liu, Xin Hua [1 ]
机构
[1] Anhui Med Univ, Anhui Prov Key Lab Major Autoimmune Dis, Sch Pharm, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
STAT; 3; Anti-tumor; Inflammation; Inhibitor; Function; Target; SMALL-MOLECULE INHIBITOR; GROWTH-SUPPRESSIVE ACTIVITY; SIGNAL TRANSDUCER; UNPHOSPHORYLATED STAT3; JAK-STAT; SERINE PHOSPHORYLATION; IN-VIVO; TYROSINE PHOSPHORYLATION; ACTIVATES TRANSCRIPTION; GENE-EXPRESSION;
D O I
10.2174/1568026619666190620145052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
STAT (Signal Transducers and Activators of Transcription) is a cellular signal transcription factor involved in the regulation of many cellular activities, such as cell differentiation, proliferation, angiogenesis in normal cells. During the study of the STAT family, STAT3 was found to be involved in many diseases, such as high expression and sustained activation of STAT3 in tumor cells, promoting tumor growth and proliferation. In the study of inflammation, it was found that it plays an important role in the anti-inflammatory and repairing of damage tissues. Because of the important role of STAT3, a large number of studies have been obtained. At the same time, after more than 20 years of development, STAT3 has also been used as a target for drug therapy. And the discovery of small molecule inhibitors also promoted the study of STAT3. Since STAT3 has been extensively studied in inflammation and tumor regulation, this review presents the current state of research on STAT3.
引用
收藏
页码:1305 / 1317
页数:13
相关论文
共 50 条
  • [1] Tumor immunology - STAT3 - a potential target for tumour immunotherapy
    Buckland, J
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (02) : 82 - 83
  • [2] Highlighted STAT3 as a potential drug target for cancer therapy
    Lee, Haeri
    Jeong, Ae Jin
    Ye, Sang-Kyu
    [J]. BMB REPORTS, 2019, 52 (07) : 415 - 423
  • [3] STAT3 as a target for cancer drug discovery
    Costantino, Luca
    Barlocco, Daniela
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (09) : 834 - 843
  • [4] Stat3 as a potential target for cancer immunotherapy
    Kortylewski, Marcin
    Yu, Hua
    [J]. JOURNAL OF IMMUNOTHERAPY, 2007, 30 (02) : 131 - 139
  • [5] STAT3 – a potential target for tumour immunotherapy
    Jenny Buckland
    [J]. Nature Reviews Immunology, 2004, 4 (2) : 82 - 82
  • [6] STAT3 in cancer inflammation and as a target for cancer therapy
    Yu, Hua
    [J]. CYTOKINE, 2011, 56 (01) : 98 - 98
  • [7] STAT3 is a potential therapeutic target in cervical cancer
    Kohut, Adrian
    Martincuks, Antons
    Santiago, Nicole Lugo
    Austria, Theresa
    Zhao, Qianqian
    Lee, Stephen
    Tergas, Ana
    Dellinger, Thanh
    Han, Ernest
    Rodriguez-Rodriguez, Lorna
    Yu, Hua
    Song, Mihae
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S137 - S138
  • [8] Stat3 as a potential therapeutic target for rheumatoid arthritis
    Takatsugu Oike
    Yuiko Sato
    Tami Kobayashi
    Kana Miyamoto
    Satoshi Nakamura
    Yosuke Kaneko
    Shu Kobayashi
    Kengo Harato
    Hideyuki Saya
    Morio Matsumoto
    Masaya Nakamura
    Yasuo Niki
    Takeshi Miyamoto
    [J]. Scientific Reports, 7
  • [9] Stat3 as a potential therapeutic target for rheumatoid arthritis
    Oike, Takatsugu
    Sato, Yuiko
    Kobayashi, Tami
    Miyamoto, Kana
    Nakamura, Satoshi
    Kaneko, Yosuke
    Kobayashi, Shu
    Harato, Kengo
    Saya, Hideyuki
    Matsumoto, Morio
    Nakamura, Masaya
    Niki, Yasuo
    Miyamoto, Takeshi
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [10] STAT3 signaling in ovarian cancer: a potential therapeutic target
    Liang, Renba
    Chen, Xishan
    Chen, Li
    Wan, Fangzhu
    Chen, Kaihua
    Sun, Yongchu
    Zhu, Xiaodong
    [J]. JOURNAL OF CANCER, 2020, 11 (04): : 837 - 848